VINKEM LABS PVT LTD

Aspidospermidine-3-carboxylic acid,4-(acetyloxy)-6,7-didehydro-15-[(2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-,methyl ester,(2β,3β,4β,5α,12R,19α)-,(2R,3R)-2,3-dihydroxybutanedioate (1:2) (salt);C′-Norvincaleukoblastine,3′,4′-didehydro-4′-deoxy-,[R-(R*,R*)]-2,3-dihydroxybutanedioate (1:2) (salt);Vinorelbine ditartrate;KW 2307;Navelbine ditartrate;Vinorelbine tartrate;Navelbine;Nor-5′-anhydrovinblastine ditartrate;Aspidospermidine-3-carboxylic acid,4-(acetyloxy)-6,7-didehydro-15-[(2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-,methyl ester,(2β,3β,4β,5α,12β,19α)-,(2R,3R)-2,3-dihydroxybutanedioate (1:2) (salt);3′,4′-Didehydro-4′-deoxy-C′-norvincaleukoblastine tartrate;892125-21-2

2,6,10,14,18,22,26,30,34-Hexatriacontanonaen-1-ol,3,7,11,15,19,23,27,31,35-nonamethyl-,(2E,6E,10E,14E,18E,22E,26E,30E)-;2,6,10,14,18,22,26,30,34-Hexatriacontanonaen-1-ol,3,7,11,15,19,23,27,31,35-nonamethyl-,(all-E)-;(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-Nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-ol;Solanesol;Nonaisoprenol;Farnesylfarnesylfarnesol;111820-07-6;540-03-4

Vincaleukoblastine,sulfate (1:1) (salt);2H-3,7-Methanoazacycloundecino[5,4-b]indole,vincaleukoblastine deriv.;1H-Indolizino[8,1-cd]carbazole,vincaleukoblastine deriv.;29060LE;NSC 49842;Velban;Velbe;Vinblastine sulfate;Vincaleucoblastine sulfate;Vincaleukoblastine sulfate;Exal;VLB monosulfate;Velsar;Alkaban-AQ

Vincaleukoblastine,22-oxo-,sulfate (1:1);Leurocristine,sulfate (1:1) (salt);Leurocristine sulfate;Vincaleukoblastine,22-oxo-,sulfate (1:1) (salt);NSC 67574;Oncovin;Vincristine sulfate;Onkovin;Vincasar PFS;Kyocristine;Vincrisul;VCR sulfate;Lilly 37231;Novopharm;Marqibo;Vincristine hydrogen sulfate;Vincristine sulfate liposome injection